Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Risedronate Sodium Tablets.

Function and indication:
Used to treat and prevent osteoporosis in postmenopausal women.
Usage and dosage:
The dosage and usage of different dosage forms and specifications of this product may vary. Please read the specific drug instructions for use, or follow the doctor’s advice. For oral administration, it is necessary to take it in an upright position at least 30 minutes before meals, with a cup (about 200ml) of water. It is not advisable to lie in bed within 30 minutes after taking the medicine. The dosage is once a day, 5mg at a time.
Adverse reactions:
1. Digestive system: It can cause upper gastrointestinal disorders, manifested as dysphagia, esophagitis, esophageal or gastric ulcers, and can also cause diarrhea, abdominal pain, nausea, constipation, etc. 2. Others: such as flu-like syndrome, headache, dizziness, rash, joint pain, etc.
The following patients are prohibited: 1. Those who are known to be allergic to this product. 2. Patients with hypocalcemia. 3. Those who have difficulty standing or sitting within 30 minutes.

Risedronate sodium tablets are a class of bisphosphonate anti-osteoporosis drugs, and its main ingredient is risedronate sodium. Bisphosphonates are one of the most widely used and effective anti-bone resorption drugs. They are clinically used to treat and prevent osteoporosis in postmenopausal women.
During the perimenopausal period and within 10 years after menopause, bone metabolism is in a high-conversion state. Risedronate sodium tablets bind to hydroxyapatite in the bone and can specifically bind to the bone surface where bone remodeling is active, inhibiting osteoclast function, thereby inhibiting bone resorption, and can also reduce bone transformation and absorption at the site of bone remodeling, effectively reducing the risk of osteoporotic fractures and increasing bone density.